What this session covers
Generative AI has lowered the cost of producing another draft, another variation, another localization. Life sciences teams are creating more content than ever, across more channels and more markets. What hasn't changed is the number of people available to review and approve it. Most AI business cases stop at the drafting stage.
In this session, Vodori and Compliance Forward look at what actually happens after the first draft. They examine where AI is delivering real value in regulated content operations, where it quietly moves work downstream instead of removing it, and what it takes to build an AI strategy that improves the full content lifecycle rather than one stage of it.